DETERMINATION OF CYSTIC FIBROSIS MUTATION FREQUENCY IN PRETERM AND TERM NEONATES WITH RESPIRATORY TRACT PROBLEMS
Tanriverdi S1, Polat M, Onay H
*Corresponding Author: Sema Tanriverdi, M.D., Assistant Professor, Department of Pediatrics, Division of Neonatology, Manisa Celal Bayar University Medical School, Uncubozkoy, 45030 Yunusemre, Manisa, Turkey. Tel: +90-236-236-0330. Fax: +90-236-233-8040. E-mail: sema.tanriverdi@cbu.edu.tr
page: 25

RESULTS

Forty babies, 20 with respiratory distress and 20 babies without respiratory distress, were included in the study. Demographic characteristics of the infants revealed that the mean gestational age was 36.22 ± 3.89 weeks. Twenty-one of the infants were born preterm and 19 were born at term. Twenty-two were girls and 18 were boys. The mean birth weight was 2775.5 ± 952.9 g, the mean birth height was 47.07 ± 5.45 cm and the mean head circumference was 33.02 ± 3.2 cm. Demographic characteristics of the babies in the control and patients groups are shown in Table 1. In the patient group, the mean gestational age was 34.25 ± 4.65 weeks; 14 infants were born preterm and six were born at term. In the control group, the mean gestational age was 38.2 ± 1.15 weeks; seven of them were born preterm and 13 were born at term. The prenatal histories taken from the patient and control groups revealed that the maternal age was similar in both groups. No significant difference was found between the patient and the control groups with regard to incidence of placental abruption, placenta previa, chorioamnionitis, gestational diabetes, diabetes mellitus, preeclampsia and eclampsia, and prenatal steroid administration. The pathologies and treatments of infants admitted to the neonatal intensive care unit in the patient group are listed in Table 2. The mean duration of stay on mechanical ventilation in the patient group was 2.25 ± 4.49 days, and the mean duration of oxygen therapy was 13.35 ± 20.71 days. The mean length of hospital stay in the patient group was 24.65 ± 21.32 days. Of the 20 infants in the control group, 14 were admitted to the neonatal intensive care unit due to hyperbilirubinemia, one for urinary tract infection, four for hypernatremic dehydration, and one for intrauterine growth restriction. The mean length of hospital stay in the control group was 4.75 ± 1.97 days. When the clinical symptoms and signs of respiratory distress in 20 infants in the patient group were taken into account, four had a cough, five were wheezing, 10 were grunting, three had apnea, 19 had tachypnea, 15 had retraction, and 12 had findings in lung auscultation (rales/ rhonchi) (Table 3). When the laboratory findings of 20 infants in the patient group were examined, five of them had a positive C-reactive protein (CRP). The mean CRP value was 0.59 ± 1.14 mg/dl. Ten of the infants had leuko-cytosis with a mean leukocyte value of 11651 ± 5109.40 mm³. Two of the infants had thrombocytopenia, the average platelet count was 258.45 ± 11.6402.42 mm³. Five infants had metabolic acidosis. The mean values of the parameters were as follows: pH 7.31 ± 0.11, bicarbonate (HCO3) 21.44 ± 3.34 mmol/L, base deficit –3.36 ± 4.42, partial pressure of carbon dioxide (PCO2) 47.61 ± 13.16 mmHg and partial pressure of oxygen (pO2) 57.39 ± 40.56 mmHg. With regard to the radiological findings of 20 infants in the patient group, 14 had lung infiltration and six had a ground-glass appearance compatible with respiratory distress syndrome (RDS). In the control group, CFTR gene analysis was normal in 14 infants, E1228G (c.3683A>G) heterozygosity was detected in one, E217G (c.650A>G) heterozygosity in one, E632TfsX9 (c.1894_1895delAG) heterozygosity in one, I807M (c.2421A>G) heterozygosity in two, and S573F (c.1718C>T) heterozygosity in one (Table 4). Of the six patients in the control group with heterozygous mutations, five were hospitalized for hyperbilirubinemia and one for hypernatremic dehydration. The CFTR gene analysis was normal in 16 infants with respiratory distress in the patient group, A46D (c.137C>A) heterozygosity was detected in one, D1312G (c.3935A>G) heterozygosity in one, R117H (c.350G>A) heterozygosity one and S1426p (c.4276T>C) heterozygosity in one (Table 5). Heterozygous mutations on the CFTR gene were detected in 10 of 40 infants in the patient and control groups included in the study. The symptoms and diagnoses of these patients are presented in Table 6. There was no significant difference in CFTR gene analysis in the control and the patient groups (p = 0.340). In the patient group, the mean hospitalization time of 20 symptomatic babies was 24.65 ± 21.32 days, while the mean hospitalization time of four babies with symptomatic and heterozygous mutations was 27.50 ± 26.33 days, no statistically significant difference was found (p = 0.128).



Number 27
VOL. 27 (2), 2024
Number 27
VOL. 27 (1), 2024
Number 26
Number 26 VOL. 26(2), 2023 All in one
Number 26
VOL. 26(2), 2023
Number 26
VOL. 26, 2023 Supplement
Number 26
VOL. 26(1), 2023
Number 25
VOL. 25(2), 2022
Number 25
VOL. 25 (1), 2022
Number 24
VOL. 24(2), 2021
Number 24
VOL. 24(1), 2021
Number 23
VOL. 23(2), 2020
Number 22
VOL. 22(2), 2019
Number 22
VOL. 22(1), 2019
Number 22
VOL. 22, 2019 Supplement
Number 21
VOL. 21(2), 2018
Number 21
VOL. 21 (1), 2018
Number 21
VOL. 21, 2018 Supplement
Number 20
VOL. 20 (2), 2017
Number 20
VOL. 20 (1), 2017
Number 19
VOL. 19 (2), 2016
Number 19
VOL. 19 (1), 2016
Number 18
VOL. 18 (2), 2015
Number 18
VOL. 18 (1), 2015
Number 17
VOL. 17 (2), 2014
Number 17
VOL. 17 (1), 2014
Number 16
VOL. 16 (2), 2013
Number 16
VOL. 16 (1), 2013
Number 15
VOL. 15 (2), 2012
Number 15
VOL. 15, 2012 Supplement
Number 15
Vol. 15 (1), 2012
Number 14
14 - Vol. 14 (2), 2011
Number 14
The 9th Balkan Congress of Medical Genetics
Number 14
14 - Vol. 14 (1), 2011
Number 13
Vol. 13 (2), 2010
Number 13
Vol.13 (1), 2010
Number 12
Vol.12 (2), 2009
Number 12
Vol.12 (1), 2009
Number 11
Vol.11 (2),2008
Number 11
Vol.11 (1),2008
Number 10
Vol.10 (2), 2007
Number 10
10 (1),2007
Number 9
1&2, 2006
Number 9
3&4, 2006
Number 8
1&2, 2005
Number 8
3&4, 2004
Number 7
1&2, 2004
Number 6
3&4, 2003
Number 6
1&2, 2003
Number 5
3&4, 2002
Number 5
1&2, 2002
Number 4
Vol.3 (4), 2000
Number 4
Vol.2 (4), 1999
Number 4
Vol.1 (4), 1998
Number 4
3&4, 2001
Number 4
1&2, 2001
Number 3
Vol.3 (3), 2000
Number 3
Vol.2 (3), 1999
Number 3
Vol.1 (3), 1998
Number 2
Vol.3(2), 2000
Number 2
Vol.1 (2), 1998
Number 2
Vol.2 (2), 1999
Number 1
Vol.3 (1), 2000
Number 1
Vol.2 (1), 1999
Number 1
Vol.1 (1), 1998

 

 


 About the journal ::: Editorial ::: Subscription ::: Information for authors ::: Contact
 Copyright © Balkan Journal of Medical Genetics 2006